Study S001273

Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06215196
Acronym: ESSENCE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: COMPLETED
Enrollment: 81
Start: 2023-04-14
Primary completion: 2023-06-28
Lead sponsor: S.LAB (SOLOWAYS)
Conditions: Overweight and Obesity
Interventions: DIETARY_SUPPLEMENT:Fiber Supplement Group; OTHER:placebo
Results posted: FALSE

Registered primary outcomes

Percentage change in body weight from baseline [180 days]
Achievement of a reduction in body weight of 5% or more from baseline. [180 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.